$GALT
Galectin Therapeutics Inc.
XNAS•Health Care•Pharmaceutical Preparations
$3.69
▼-4.65%-$0.180
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateGalectin Therapeutics Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is GALT down today? It is at $3.69 (-4.65%), and our scanner flagged it 13 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GALT spikes, and full due diligence on GALT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GALT 13 times in the last 30 days. Create a free account to track $GALT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GALT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GALT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Uihlein Richard E Director | Other | 34.38M 34.1% of company | added 100% | 44.74M | $103.1M at $3.00 | Jul 31, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -16K 0.02% of company | n/a | n/a | $83K at $5.13 | Jul 14, 26 |
Jamil Khurram Officer | Other | 16K 0.02% of company | n/a | 16K | $49K at $3.04 | Jul 14, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -47K 0.05% of company | n/a | n/a | $239K at $5.04 | Jun 29, 26 |
Jamil Khurram Officer | Other | 47K 0.05% of company | n/a | 47K | $119K at $2.50 | Jun 29, 26 |
Shlevin Harold H. Director | Sold (automatic/other) | -22K 0.02% of company | sold 77% | 7K | $112K at $5.04 | Jun 29, 26 |
Shlevin Harold H. Director | Other | 22K 0.02% of company | added 100% | 29K | $27K at $1.23 | Jun 29, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -5K | n/a | n/a | $23K at $5.00 | Jun 26, 26 |
Jamil Khurram Officer | Other | 5K | n/a | 3K | $10K at $2.20 | Jun 26, 26 |
Shlevin Harold H. Director | Sold (automatic/other) | -8K | sold 54% | 7K | $39K at $5.00 | Jun 26, 26 |
Shlevin Harold H. Director | Other | 8K | added 100% | 14K | $10K at $1.23 | Jun 26, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -8K | n/a | n/a | $24K at $3.14 | Jun 23, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on GALT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GALT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GALT last traded at $3.69, down 4.65% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Galectin Therapeutics Inc. (GALT) is next expected to report earnings on Friday, November 13, 2026, about 31 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GALT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GALT 13 times in the last 30 days.
GALT (Galectin Therapeutics Inc.) trades on XNAS, with a market cap of about $372M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GALT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GALT discussion
Sign in to ask a question or join the discussion.